Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dhanvantri Jeevan Rekha's quarterly market cap
declined
from Sep. 2025 (₹121.3 Mil) to Dec. 2025 (₹102.6 Mil) but then
increased
from Dec. 2025 (₹102.6 Mil) to Mar. 2026 (₹103.0 Mil).
Dhanvantri Jeevan Rekha's annual market cap
declined
from Mar. 2024 (₹100.4 Mil) to Mar. 2025 (₹84.7 Mil) but then
increased
from Mar. 2025 (₹84.7 Mil) to Mar. 2026 (₹103.0 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Dhanvantri Jeevan Rekha's Enterprise Value for Today is ₹74.9 Mil.
Dhanvantri Jeevan Rekha (BOM:531043) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Dhanvantri Jeevan Rekha Market Cap Related Terms
Dhanvantri Jeevan Rekha Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:531043 vs HCA, THC, DVA: Market Cap Comparison
For the Medical Care Facilities subindustry, Dhanvantri Jeevan Rekha's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dhanvantri Jeevan Rekha Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dhanvantri Jeevan Rekha's Market Cap distribution charts can be found below:
* The bar in red indicates where Dhanvantri Jeevan Rekha's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Dhanvantri Jeevan Rekha's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dhanvantri Jeevan Rekha (BOM:531043) has a Market Cap of ₹111.9 Mil as of Jul. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dhanvantri Jeevan Rekha and its competitors. According to the industry distribution chart, Dhanvantri Jeevan Rekha ranks #680 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 97.4%.
Is Dhanvantri Jeevan Rekha's Market Cap too high?
Dhanvantri Jeevan Rekha's current Market Cap is ₹111.9 Mil. Based on the distribution chart, Dhanvantri Jeevan Rekha ranks #680 out of 698 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dhanvantri Jeevan Rekha has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dhanvantri Jeevan Rekha's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dhanvantri Jeevan Rekha ranks #680 out of 698 companies for Market Cap. This places Dhanvantri Jeevan Rekha in the lower half of its industry. The industry median Market Cap is 101.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 101.13, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Dhanvantri Jeevan Rekha and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 101.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dhanvantri Jeevan Rekha's current Market Cap is ₹111.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dhanvantri Jeevan Rekha stock overvalued right now?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha (BOM:531043) is currently considered Fairly Valued. The stock's GF Value™ is ₹24.97, compared to a current price of ₹27.30 — trading 9.3% above its estimated fair value. The current Market Cap is ₹111.9 Mil. Dhanvantri Jeevan Rekha's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Dhanvantri Jeevan Rekha (BOM:531043), the current Market Cap is ₹111.9 Mil as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dhanvantri Jeevan Rekha (BOM:531043) Overvalued in 2026?
Based on GuruFocus' analysis, Dhanvantri Jeevan Rekha stock appears to be overvalued.
The current stock price of ₹27.30 is trading 9.3% above its estimated GF Value™ of ₹24.97.
GuruFocus considers Dhanvantri Jeevan Rekha to be Fairly Valued.
Key valuation signals for BOM:531043:
Market Cap: ₹111.9 Mil
GF Value™: ₹24.97 vs. price of ₹27.30 (9.3% above fair value)
No single metric tells the full story. See the BOM:531043 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dhanvantri Jeevan Rekha Ltd is engaged in providing diagnostic and therapeutic services and has extended its scope of diagnostic and hospital services by providing a fully operational Cath Lab, catering to higher end needs of the cardiac patients including Angiography, Angioplasty, Pacemaker Implantation, Valvuloplasty etc. The hospital has expanded its services to include a wide range of specialties such as Cardiology, Neurology, Orthopedics, Radiology, Gastroenterology, General Surgery, Urology, and General Medicine.
56GF Score
Get the complete analysis for BOM:531043
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531043 has been successfully added to your 
